Tinavi Medical Plans to Acquire 62% Stake in Shanghai Orthopaedics, Constituting a Major Asset Restructuring; Trading to Resume Tomorrow

Corporate ActionM&A · Partnership
โดย 数据宝·Read original
Summary · why it matters

Tinavi Medical announced plans to acquire a 62% stake in Shanghai Orthopaedics, expected to constitute a major asset restructuring, with trading in its shares to resume tomorrow. Yongding Co.'s controlling subsidiary has received purchase orders for high-power laser chip products worth approximately 1.133 billion yuan over the past month. Xingyun Technology's wholly-owned subsidiary has signed a supplementary agreement for computing power services, increasing the contract value to 3.053 billion yuan, up 201.14% from the original agreement. Jiayun Technology shareholder Ruineng Co. plans to acquire an 18.31% stake through a negotiated transfer, and trading in the shares will resume. Lianchuang Electronics' controlling shareholder is set to change to Shouxian Xinqiao, and trading in the shares will resume. GigaDevice Chairman Zhu Yiming has proposed a buyback of A-shares worth between 1 billion and 2 billion yuan for cancellation, and plans to increase his holdings by no less than 1 billion yuan. Sinosun Technology is planning a change of control, and trading in its shares has been suspended. Zijin Mining's controlling subsidiary has terminated its acquisition of Union Gold and plans to subscribe for a 9.2% stake in the company. Huawen Media has had its delisting risk warning removed but will continue to be subject to other risk warnings, with its stock abbreviation changed to ST Huawen. Hailiang Co.'s controlling shareholder has received a commitment letter for an 860 million yuan shareholding increase loan. Huajin Co. Vice General Manager Yan Zenghui has been placed under investigation and subjected to detention measures. Hengrui Medicine's insulin degludec injection has been approved for marketing for the treatment of type 2 diabetes in adults, making it the first domestically developed long-acting insulin analogue in China.

Impact on stocks 12

Others± Mixed · 12 stocks
Zhejiang Hailiang Co Ltd
002203
▲ PositiveCapitalrelevance

Controlling shareholder received commitment letter for 860 million yuan shareholding increase loan.

GigaDevice Semiconductor(Beiji
603986
▲ PositiveCapitalrelevance

GigaDevice Chairman proposes A-share buyback of 1-2 billion yuan and plans to increase holdings by no less than 1 billion yuan.